Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose

Details for Australian Patent Application No. 2009251328 (hide)

Owner GlycoFi, Inc.

Inventors Stadheim, Terrance A.; Davidson, Robert C.; Wildt, Stefan; Sethuraman, Natarajan

Agent Spruson & Ferguson

Pub. Number AU-A-2009251328

PCT Pub. Number WO2009/146362

Priority 61/130,422 30.05.08 US

Filing date 28 May 2009

Wipo publication date 3 December 2009

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/146362 Priority application(s): WO2009/146362

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009251331-Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists

2009251324-Imidazopyridine and related analogs as sirtuin modulators